Hershey gives grant to Harrisburg University to create research lab
HARRISBURG, Pa. — A university and a chocolate giant have joined forces to develop a sensory science and consumer research program.
The Harrisburg University of Science and Technology and Hershey said their initiative will be developed, thanks to a grant of $90,000 from Hershey, to equip a new sensory science and consumer research laboratory and cover other start-up costs during the program’s first two years. The college will conduct consumer taste tests on a range of confectionery products, including Hershey’s chocolate. Consumer insights obtained from the lab’s research will guide product development efforts, the two said.
The program’s research results then will be integrated with sensory testing conducted at The Hershey Co.’s Technical Center in Hershey, Pa., where professional sensory panels and employee panels provide feedback that guides ongoing new product development.
The university expects to complete the lab, which will be located at the university’s school campus in downtown Harrisburg, in February.
“We are creating a unique research program where students will learn applied science and technology that has meaningful, real-world applications,” said Eric Darr, EVP and provost at Harrisburg University. “We want to thank Hershey for their support. This research will not only benefit the innovation work of one of the world’s best-known companies, it will give students the opportunity to gain practical experience that will prepare them for science and technology jobs.”
Price Chopper set to buy N.Y. indy pharmacy
SCHENECTADY, N.Y. — Supermarket chain Price Chopper will buy out an independent pharmacy in Malta, N.Y., according to media reports.
News media in upstate New York reported that Price Chopper would buy Apple Community Pharmacy and hire all of its 15 employees.
The supermarket chain will operate its pharmacy at the same location as Apple and offer the same programs and services it offers at its own stores, pending completion of the pharmacy at its store in Malta.
Older physicians less likely to prescribe generic medications
WOONSOCKET, R.I. — While a majority of physicians are comfortable with generic medications, there is a small segment who still have negative perceptions about the effectiveness and quality of generic drugs, and that may lead to doctors prescribing unnecessarily expensive medications, according to a new study by researchers at Harvard University, Brigham and Women’s Hospital and CVS Caremark.
In a study published in the Annals of Pharmacotherapy, the researchers stated, "Overall, we found that the majority of physicians are comfortable with the efficacy of generic medications and are comfortable using generics themselves. However, there is a meaningful proportion who express concerns about generics. These beliefs could represent an important barrier to greater generic use and could contribute to elevated prescription costs for patients, insurance providers and society."
According to the study, 23% of doctors have negative perceptions of the effectiveness and quality of generic medications.
"While there are many studies about how consumers and patients view generics, we thought it would be important to also look at the perception of generics by prescribers, because understanding the physician’s perception can help us determine if there are other potential barriers to the greater use of generics," stated lead author of the study William Shrank of Brigham and Women’s Hospital and Harvard. "We don’t have clear insight as to what might influence a prescriber’s behavior, and as we look to develop programs to encourage more cost-effective pharmacy care, this is an area industry and policy-makers should be reviewing. We know that if we help patients access less expensive medications, they are more likely to take them."
The researchers surveyed more than 2,700 physicians and received 506 responses from prescribers representing both specialists and general practitioners. More than 60% of the physicians surveyed were between ages 35 and 54 years, with physicians older than 55 years representing about 30% of the survey group; physicians ages 25 to 34 years made up 9% of the respondents. Physicians ages 55 years or older were 3.3 times more likely to have negative perceptions about generics than those between ages 25 and 34 years.
While the doctors said they were aware some patients struggle with the costs of medications, there was little relationship between the doctor’s perception of cost burden and their perceptions of generics, according to researchers.
In addition, when asked how they were informed about the market entry of a generic medication, 75% said they received their information from the pharmaceutical representatives. Other sources of information included medical journals (42%), colleagues (40%) and pharmaceutical mailings and literature (38%).
The researchers also indicated that the study was limited by the sample that was surveyed. While the sample was drawn from a large source, the response rate was low; physicians who did respond may have differed from the overall population.
"Payers and policy-makers attempting to stimulate cost-effective medication use should consider educating physicians, particularly older ones, to improve their comfort with generics," the study concluded.
The study is a product of CVS Caremark’s previously announced three-year collaboration with Harvard University and Brigham and Women’s Hospital to research pharmacy claims data to better understand patient behavior, particularly around medication adherence.